Globe Life Inc. (GL)

FairStock Score: 73/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look at Globe Life as a steady specialty insurer, not a fast grower. It sells life and supplemental health products to lower- and middle-income families, a niche where routine premium collection and agent relationships can create a modest moat, though I would not call it wide. The filed numbers show consistency: in fiscal year 2023 revenue was $5.4B and net income $970.8M; in fiscal year 2024 revenue was $5.8B and net income $1.1B; in fiscal year 2025 revenue was $6.0B and net income $1.2B, with diluted EPS of $10.07, $11.94 and $14.07 respectively. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $1.6B, net income $287.7M and diluted EPS $3.65, better than fiscal Q2 2025, the quarter ended 2025-06-30, when revenue was $1.5B, net income $252.7M and diluted EPS $3.05. At the 2026-10-26 close of $156.82, FairStock's calculations put P/E at 10.43, P/B at 1.96, ROE at 20.94%, ROCE at 3.36%, D/E at 0.56 and PEG at 1.64. The high ROE and lowish P/E are attractive, and the 0.76% dividend and 0.46 beta add defensiveness. Still, P/B near 2 is no asset bargain, ROCE is modest, and the 6/9 Piotroski score says financial strength is good but not exceptional. FairStock labels it a STALWART—steady growth, with profit up 9.7% a year over five years and revenue up 4.8%—which fits the evidence. For an insurer, I would want reserve development, underwriting margins and capital ratios; CET1, NIM and combined ratio are not in this data. My conclusion: a respectable, steady business at a fair-to-modestly-cheap price, not a bargain.

In plain English: Globe Life sells life insurance and extra health coverage to working and middle-income families in the U.S. The company makes good profits, has grown steadily, and pays a small dividend. At the 2026-10-26 closing price, the shares look a little cheap compared with earnings and accounting value, but not a screaming bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer